Brainstorm CFO Preetam Shah resigns, Controller Alla Patlis named Interim CFO

BRAINSTORM CELL THERAPEUTICS INC.

CFO Preetam Shah resigned effective Aug 31, 2021; no disagreement with the Company or Board.
Controller Alla Patlis appointed Interim CFO effective upon Shah's departure if no permanent CFO named.
Patlis has served as Controller since Dec 2012 and previously as Interim CFO in 2015 and 2016-2017.
No change in Patlis's current compensation for the additional Interim CFO role.
Company plans to interview candidates for a permanent CFO successor.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Preetam Shah

Chief Financial Officer

BCLI · BRAINSTORM CELL THERAPEUTICS INC.

Effective: 2021-08-31
Successor: Alla Patlis
Filed: August 25, 2021, 7:59 PM ET

On August 20, 2021, Preetam Shah, the Chief Financial Officer (and principal financial and accounting officer) of Brainstorm Cell Therapeutics Inc. (the “Company”), provided the Company with notice of his intent to resign from the Company, effective August 31, 2021.

Appointed (interim)

Alla Patlis

Interim Chief Financial Officer

BCLI · BRAINSTORM CELL THERAPEUTICS INC.

Effective: 2021-08-31
Filed: August 25, 2021, 7:59 PM ET

The Board of Directors of the Company has appointed Alla Patlis, the Company’s current Controller, as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Shah’s resignation if a permanent Chief Financial Officer is not appointed prior to that time.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Preetam Shah resigned as Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On August 20, 2021, Preetam Shah, the Chief Financial Officer (and principal financial and accounting officer) of Brainstorm Cell Therapeutics Inc. (the “Company”), provided the Company with notice of his intent to resign from the Company, effective August 31, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alla Patlis was appointed as Interim Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

The Board of Directors of the Company has appointed Alla Patlis, the Company’s current Controller, as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Shah’s resignation if a permanent Chief Financial Officer is not appointed prior to that time.

View on SEC.gov

BRAINSTORM CELL THERAPEUTICS INC. filing history →

Source: SEC EDGAR

accession 0001104659-21-109371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.